1. Home
  2. AKA vs ANIX Comparison

AKA vs ANIX Comparison

Compare AKA & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo a.k.a. Brands Holding Corp.

AKA

a.k.a. Brands Holding Corp.

HOLD

Current Price

$10.78

Market Cap

105.4M

ML Signal

HOLD

Logo Anixa Biosciences Inc.

ANIX

Anixa Biosciences Inc.

HOLD

Current Price

$3.81

Market Cap

108.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AKA
ANIX
Founded
2018
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
105.4M
108.5M
IPO Year
2021
2013

Fundamental Metrics

Financial Performance
Metric
AKA
ANIX
Price
$10.78
$3.81
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$24.33
$8.67
AVG Volume (30 Days)
2.1K
312.4K
Earning Date
05-12-2026
05-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
12.82
EPS
N/A
N/A
Revenue
$600,208,000.00
$210,000.00
Revenue This Year
$6.14
N/A
Revenue Next Year
$4.89
N/A
P/E Ratio
N/A
N/A
Revenue Growth
4.44
N/A
52 Week Low
$8.42
$2.32
52 Week High
$16.38
$5.46

Technical Indicators

Market Signals
Indicator
AKA
ANIX
Relative Strength Index (RSI) N/A 69.64
Support Level N/A $2.77
Resistance Level N/A $4.52
Average True Range (ATR) 0.00 0.25
MACD 0.00 0.05
Stochastic Oscillator 0.00 95.31

Price Performance

Historical Comparison
AKA
ANIX

About AKA a.k.a. Brands Holding Corp.

a.k.a. Brands Holding Corp is a portfolio of fashion brands, including Princess Polly, Culture Kings, Petal & Pup, and mnml. Through these brands, the company reaches next-generation consumers who seek fashion inspiration on social media and mainly shop online. The portfolio consists of two women's brands, Princess Polly and Petal & Pup, and two streetwear brands, Culture Kings and mnml. The company generates the majority of its revenue from the United States.

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.

Share on Social Networks: